Challenges in the development of magnetic particles for therapeutic applications.
about
Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cellsAn inverse problem approach to recovery of in vivo nanoparticle concentrations from thermal image monitoring of MR-guided laser induced thermal therapy.Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.Covalent assembly of nanoparticles as a peptidase-degradable platform for molecular MRI.Temperature monitoring utilising thermoacoustic signals during pulsed microwave thermotherapy: a feasibility study.Review of Neurosurgical Fluorescence Imaging Methodologies.Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering.Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study.Biocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.Highly efficient mesenchymal stem cell proliferation on poly-ε-caprolactone nanofibers with embedded magnetic nanoparticlesComputational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy.Magnetic nanoparticles: surface effects and properties related to biomedicine applicationsPrinciples and emerging applications of nanomagnetic materials in medicine.Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination.A SPION-eicosane protective coating for water soluble capsules: Evidence for on-demand drug release triggered by magnetic hyperthermiaBone regeneration in a rabbit critical femoral defect by means of magnetic hydroxyapatite macroporous scaffolds.Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.The prospective opportunities offered by magnetic scaffolds for bone tissue engineering: a reviewPhysical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review.Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.Mean-field and linear regime approach to magnetic hyperthermia of core-shell nanoparticles: can tiny nanostructures fight cancer?The role of size polydispersity in magnetic fluid hyperthermia: average vs. local infra/over-heating effects.Prospects for radiofrequency hyperthermia applicator research. I--Pre-optimised prototypes of endocavitary applicators with matching interfaces for prostate hyperplasia and cancer treatments.Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake.Effect of magnetic nanoparticle heating on cortical neuron viability.Efficacy of Dipeptide-Coated Magnetic Nanoparticles in Lung Cancer Models Under Pulsed Electromagnetic Field.On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia.Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice.A low cost synthesis method for functionalised iron oxide nanoparticles for magnetic hyperthermia from readily available materials
P2860
Q28383790-2396E56C-8086-41E0-AC3D-D05D174CEBC8Q30444965-894A7F4D-A453-4412-A472-E76C17996D90Q30465367-BB7DFCD8-692C-4EDC-A90E-D828C7A04FA3Q30839205-A1D48A33-6D3A-4FCB-9707-E964A576DE0AQ33546562-069ED145-F8FF-4FBD-96D6-AB97D8589FDEQ34023717-61574394-4A48-47A9-9854-04ABED0D001CQ34543166-A804A64E-0E70-42A2-A633-0B95857C23DEQ35254475-678799F5-2E26-4471-9279-6684F2C0760CQ35574688-058BEBA1-FE8F-4BE3-8FC4-1DC77E6F53A1Q36367977-C8A7E5CF-B962-4593-AFEF-4C6ED36EB595Q37172255-2BDF88AC-2387-4600-8990-D9376F4EBAF4Q37375294-50500914-C497-42F4-B98F-E9951A7AB1CBQ38001396-D8F3F1B2-A28A-4EA7-AF56-3E7F261716CEQ38012538-27773698-4AAF-48EF-A11B-DE096299B70FQ38257338-0D5CF78C-D813-4DC5-BDDF-5CAF712A3161Q38757280-32606486-D7C5-46F9-AF42-3A8E714D65A0Q39077003-8024D2D1-AB5A-45FA-AB88-245740208689Q39143929-72F63FA0-7F6B-4B17-87AE-4EACF54206D7Q39196839-5834B607-448C-45FF-926E-66771D7AD7F9Q39459376-079B3F3E-0485-42B7-B6DC-0E0FE5B3BCEEQ39862252-66D37A86-0E4D-4888-A043-306F0F507A4DQ40136281-47F76555-0992-44DB-94B4-C4A3607C1F20Q43438044-8F569E5B-5C10-426C-89EC-4AEF8C6E0013Q47316700-A0D3CC15-DE55-48B2-9B13-DE5C3F06C235Q48892586-1ACCA74A-7CFA-4E2D-A715-CBE8506D7FDFQ50437119-0D64EDD1-B9BB-43ED-909C-AD23540EEE5CQ51715762-50C0DC77-A2B3-43EB-844A-6917DDB1692BQ54963271-59EAF4D3-0EA4-487D-A2E1-5787B64F3ABCQ57597876-F60FA548-0B7C-4832-8886-DEE02C12794C
P2860
Challenges in the development of magnetic particles for therapeutic applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Challenges in the development of magnetic particles for therapeutic applications.
@en
Challenges in the development of magnetic particles for therapeutic applications.
@nl
type
label
Challenges in the development of magnetic particles for therapeutic applications.
@en
Challenges in the development of magnetic particles for therapeutic applications.
@nl
prefLabel
Challenges in the development of magnetic particles for therapeutic applications.
@en
Challenges in the development of magnetic particles for therapeutic applications.
@nl
P2860
P1476
Challenges in the development of magnetic particles for therapeutic applications.
@en
P2093
Stephen E Barry
P2860
P304
P356
10.1080/02656730802093679
P577
2008-09-01T00:00:00Z